Optimization of the Inclusion of Alzheimer's Disease Patients in International Multicenter Randomized Trials: Results of a National Survey Conducted in Memory Research Centers in France

被引:2
|
作者
Tchalla, A. E. [1 ,2 ]
Adam, C. [1 ]
Gayot, C. [1 ,2 ]
Cowppli-Bony, P. [4 ]
Preux, P. M. [3 ]
Dantoine, T. [1 ,2 ]
机构
[1] Ctr Hosp Univ Limoges, Serv Med Interne Geriatr, Pole Personnes Agees & Soins Domicile, Limoges, France
[2] Univ Limoges, EA 6310 HAVAE Handicap Autonomie Vieillissement, Limoges, France
[3] Univ Limoges, INSERM, Inst Epidemiol Neurol & Neurol Trop, UMR 1094, Limoges, France
[4] Unite INSERM 897, CMRR Aquitaine, Bordeaux, France
来源
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA | 2013年 / 3卷 / 01期
关键词
Alzheimer's disease; Clinical trials; Inclusion; Optimization;
D O I
10.1159/000353891
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Since 2002, with the creation of Centers of Memory Resources and Research (CMRR), considerable progress has been made in France regarding the administrative and institutional framework within which Alzheimer's disease (AD) is managed. In this study, we explore three approaches that can help optimize the inclusion of patients in clinical trials related to AD. They are as follows: to assess communication concerning clinical trials on AD in French CMRR, to analyze the internal organization of these centers concerning the dynamics of inclusion, and to evaluate screening tools used. Methods: A national, descriptive, crosssectional survey was conducted in all CMRR in France between May 1 and July 31, 2011, using a self-administered questionnaire. All investigators, subinvestigators and the relevant CMRR personnel were involved. Results: A total of 75% of the CMRR participated, and about 30% of the physicians contacted responded positively to the survey. Only 50% reported having communicated with health care professionals at least once in the previous 3 months, and less than 50% had communicated occasionally with the general public. A total of 75% of those surveyed had a research group but only half of the groups were active, 50% of the physicians did not have a consultation time dedicated to study recruitment, and 75% of the respondents had a screening tool in their CMRR but over half of them were not satisfied with it. Conclusion: This investigation provides a basis for improving the screening of patients by both internal organizational development and adaptation of tools already available. Improvement requires promoting regular communication that is appropriate and targeted to health care professionals, smaller memory centers, associations and the public, and therefore, familiarizing the whole population with clinical research on AD. (C) 2013 S. Karger AG, Basel
引用
收藏
页码:417 / 425
页数:9
相关论文
共 7 条
  • [1] Long-term treatment of patients with Alzheimer's disease in primary and secondary care: results from an international survey
    Froelich, Lutz
    Andreasen, Niels
    Tsolaki, Magda
    Foucher, Arnaud
    Kavanagh, Shane
    Van Baelen, Bart
    Schwalen, Susanne
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (12) : 3059 - 3068
  • [2] Information and Communication Technology Systems to Improve Quality of Life and Safety of Alzheimer's Disease Patients: A Multicenter International Survey
    Pilotto, Alberto
    D'Onofrio, Grazia
    Benelli, Edoardo
    Zanesco, Antonio
    Cabello, Ana
    Margeli, M. Carmen
    Wanche-Politis, Sophia
    Seferis, Kostas
    Sancarlo, Daniele
    Kilias, Dimitrios
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 23 (01) : 131 - 141
  • [3] Results of a Randomized placebo-controlled study of memory training for mildly impaired Alzheimer's disease patients
    Cahn-Weiner, DA
    Malloy, PF
    Rebok, GW
    Ott, BR
    APPLIED NEUROPSYCHOLOGY, 2003, 10 (04): : 215 - 223
  • [4] Is Australia ready for the rollout of amyloid-targeting therapies for Alzheimer's disease? Results from a national survey characterising current infrastructure capability, workforce and training needs of memory and cognition clinics
    Michaelian, Johannes C.
    Rowe, Christopher C.
    Kurrle, Susan E.
    Pond, Constance Dimity
    Woodward, Michael
    Naismith, Sharon L.
    INTERNAL MEDICINE JOURNAL, 2025,
  • [5] Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan
    Nakamura, Yu
    Kitamura, Shin
    Homma, Akira
    Shiosakai, Kazuhito
    Matsui, Daiju
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (07) : 913 - 925
  • [6] Changes in dementia treatment patterns associated with changes in the National Policy in South Korea among patients with newly diagnosed Alzheimer's disease between 2011 and 2017: results from the multicenter, retrospective CAPTAIN study
    Kim, Young Jin
    So, Ki-Youn
    Lee, Hyo Min
    Hahn, Changtae
    Song, Seung-Hoon
    Lee, Yong-Seok
    Kim, Sang Woo
    Park, Heui Cheun
    Ryu, Jaehyung
    Lee, Jung Seok
    Kang, Min Ju
    Kim, Jinran
    Lee, Yoona
    Lee, Jun Hong
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [7] Changes in dementia treatment patterns associated with changes in the National Policy in South Korea among patients with newly diagnosed Alzheimer’s disease between 2011 and 2017: results from the multicenter, retrospective CAPTAIN study
    Young Jin Kim
    Ki-Youn So
    Hyo Min Lee
    Changtae Hahn
    Seung-Hoon Song
    Yong-Seok Lee
    Sang Woo Kim
    Heui Cheun Park
    Jaehyung Ryu
    Jung Seok Lee
    Min Ju Kang
    JinRan Kim
    Yoona Lee
    Jun Hong Lee
    BMC Public Health, 24